Your browser doesn't support javascript.
loading
Transcriptomic profiling reveals distinct subsets of immune checkpoint inhibitor induced myositis.
Pinal-Fernandez, Iago; Quintana, Angela; Milisenda, Jose Cesar; Casal-Dominguez, Maria; Muñoz-Braceras, Sandra; Derfoul, Assia; Torres-Ruiz, Jiram; Pak, Katherine; Dell'Orso, Stefania; Naz, Faiza; Gutierrez-Cruz, Gustavo; Milone, Margherita; Shelly, Shahar; Duque-Jaimez, Yaiza; Tobias-Baraja, Ester; Matas-Garcia, Ana; Garrabou, Gloria; Padrosa, Joan; Ros, Javier; Trallero-Araguás, Ernesto; Walitt, Brian; Christopher-Stine, Lisa; Lloyd, Thomas E; Zhao, Chen; Swift, Shannon; Rajan, Arun; Grau-Junyent, Josep Maria; Selva-O'Callaghan, Albert; Liewluck, Teerin; Mammen, Andrew Lee.
Afiliação
  • Pinal-Fernandez I; Muscle Disease Unit, National Institute of Arthritis and Musculoskeletal and Skin Diseases, Bethesda, Maryland, USA andrew.mammen@nih.gov iago.pinalfernandez@nih.gov.
  • Quintana A; Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Milisenda JC; Muscle Disease Unit, National Institute of Arthritis and Musculoskeletal and Skin Diseases, Bethesda, Maryland, USA.
  • Casal-Dominguez M; Systemic Autoimmune Disease Unit, Vall d'Hebron Research Institute, Barcelona, Catalunya, Spain.
  • Muñoz-Braceras S; Muscle Disease Unit, National Institute of Arthritis and Musculoskeletal and Skin Diseases, Bethesda, Maryland, USA.
  • Derfoul A; Muscle Research Unit, Internal Medicine Service, Hospital Clinic, Barcelona, Catalunya, Spain.
  • Torres-Ruiz J; CIBERER, IDIBAPS and University of Barcelona, Barcelona, Catalunya, Spain.
  • Pak K; Muscle Disease Unit, National Institute of Arthritis and Musculoskeletal and Skin Diseases, Bethesda, Maryland, USA.
  • Dell'Orso S; Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Naz F; Muscle Disease Unit, National Institute of Arthritis and Musculoskeletal and Skin Diseases, Bethesda, Maryland, USA.
  • Gutierrez-Cruz G; Muscle Disease Unit, National Institute of Arthritis and Musculoskeletal and Skin Diseases, Bethesda, Maryland, USA.
  • Milone M; Muscle Disease Unit, National Institute of Arthritis and Musculoskeletal and Skin Diseases, Bethesda, Maryland, USA.
  • Shelly S; Department of Immunology and Rheumatology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico city, Mexico.
  • Duque-Jaimez Y; Muscle Disease Unit, National Institute of Arthritis and Musculoskeletal and Skin Diseases, Bethesda, Maryland, USA.
  • Tobias-Baraja E; Muscle Disease Unit, National Institute of Arthritis and Musculoskeletal and Skin Diseases, Bethesda, Maryland, USA.
  • Matas-Garcia A; Muscle Disease Unit, National Institute of Arthritis and Musculoskeletal and Skin Diseases, Bethesda, Maryland, USA.
  • Garrabou G; Muscle Disease Unit, National Institute of Arthritis and Musculoskeletal and Skin Diseases, Bethesda, Maryland, USA.
  • Padrosa J; Division of Neuromuscular Medicine, Department of Neurology, Mayo Clinic, Rochester, Minnesota, USA.
  • Ros J; Department of Neurology, Rambam Health Care Campus, Bruce Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel, Haifa, Israel.
  • Trallero-Araguás E; Muscle Research Unit, Internal Medicine Service, Hospital Clinic, Barcelona, Catalunya, Spain.
  • Walitt B; Muscle Research Unit, Internal Medicine Service, Hospital Clinic, Barcelona, Catalunya, Spain.
  • Christopher-Stine L; Muscle Research Unit, Internal Medicine Service, Hospital Clinic, Barcelona, Catalunya, Spain.
  • Lloyd TE; CIBERER, IDIBAPS and University of Barcelona, Barcelona, Catalunya, Spain.
  • Zhao C; Muscle Research Unit, Internal Medicine Service, Hospital Clinic, Barcelona, Catalunya, Spain.
  • Swift S; CIBERER, IDIBAPS and University of Barcelona, Barcelona, Catalunya, Spain.
  • Rajan A; CIBERER, IDIBAPS and University of Barcelona, Barcelona, Catalunya, Spain.
  • Grau-Junyent JM; Medical Oncology, Vall d'Hebron University Hospital, Barcelona, Catalunya, Spain.
  • Selva-O'Callaghan A; Rheumatology Department, Vall d'Hebron University Hospital, Barcelona, Catalunya, Spain.
  • Liewluck T; National Institute of Neurological Diseases and Stroke, National Institutes of Health, Bethesda, Maryland, USA.
  • Mammen AL; Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Ann Rheum Dis ; 82(6): 829-836, 2023 06.
Article em En | MEDLINE | ID: mdl-36801811
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doenças Autoimunes / Miosite de Corpos de Inclusão / Dermatomiosite / Miocardite / Miosite Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doenças Autoimunes / Miosite de Corpos de Inclusão / Dermatomiosite / Miocardite / Miosite Idioma: En Ano de publicação: 2023 Tipo de documento: Article